SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-007095
Filing Date
2024-03-06
Accepted
2024-03-06 18:00:10
Documents
2
Period of Report
2024-03-04

Document Format Files

Seq Description Document Type Size
1 form4-03062024_060304.html 4  
1 form4-03062024_060304.xml 4 4055
2 ex24-03062024_060304.htm EX-24 5327
  Complete submission text file 0001415889-24-007095.txt   10997
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
Vistagen Therapeutics, Inc. (Issuer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 255 N CALDWELL CIRCLE DOWNINGTOWN PA 19335
Business Address
Cunningham Ann Michelle (Reporting) CIK: 0001764572 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37761 | Film No.: 24727375